Chloroquine diphosphate bearing dextran nanoparticles augmented drug delivery and overwhelmed drug resistance in Plasmodium falciparum parasites
about
P. Knowlesi Trial of Artesunate-mefloquine Versus ChloroquineEfficacy of 3 Regimens of Chloroquine and Primaquine for Treatment of P. Vivax Malaria, Cruzeiro do Sul, Acre, BrazilArtesunate Plus Sulfadoxine-Pyrimethamine Versus Chloroquine for Vivax MalariaAtheroma Reduction With Chloroquine in Patients With the Metabolic Syndrome (ARCH-MS)Chloroquine to Treat People With Metabolic Syndrome Aim2 (ARCH-MS)Chloroquine and Coartem for Treatment of Symptomatic Children With Plasmodium Falciparum in Guinea BissauAzithromycin Plus Chloroquine Versus Mefloquine In the Treatment of Uncomplicated P. Falciparum Malaria.Evaluate Parasitological Clearance Rates And Pharmacokinetics Of The Combination Of Azithromycin And Chloroquine In Asymptomatic Pregnant Women With Falciparum Parasitemia In AfricaEvaluate Azithromycin Plus Chloroquine And Sulfadoxine Plus Pyrimethamine Combinations For Intermittent Preventive Treatment Of Falciparum Malaria Infection In Pregnant Women In AfricaStudy on the Treatment of Vivax MalariaMalaria Challenge in Healthy VolunteersP. Knowlesi Trial of Artemether-lumefantrine vs ChloroquineTafenoquine/Chloroquine DDI StudyProliferative Lupus Nephritis Treatment With Chloroquine and HydroxychloroquineAzithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine For The Treatment Of Uncomplicated, Symptomatic Falciparum Malaria In Southeast AsiaAzithromycin Plus Chloroquine Versus Atovaquone-Proguanil For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria In South AmericaCiPA Phase 1 ECG Biomarker Validation StudyChloroquine as an Anti-autophagic Radiosensitizing Drug in Stage I-III Small Cell Lung CancerChloroquine Population Pharmacokinetics in Pre and Post-partum WomenSanaria™ PfSPZ Challenge VaccineImmunization With Plasmodium Falciparum Sporozoites Under Chloroquine Versus Mefloquine ProphylaxisChloroquine for Malaria in PregnancyClinical Trial for Evaluation of Ethnic Differences in Pharmacokinetics of Chloroquine, an Anti-malarial DrugExperimental Human Malaria Infection After Immunization With Plasmodium Falciparum Sporozoites Under Chloroquine ProphylaxisSafety, Tolerability, Immunogenicity and Protective Efficacy of PfSPZ Vaccine and PfSPZ-CVac in Indonesian Adults Against Naturally-Transmitted MalariaCabergoline Combined Hydroxychloroquine/Chloroquine to Treat Resistant ProlactinomasEfficacy and Tolerability of Artesunate Amodiaquine Versus Chloroquine in the Treatment of Uncomplicated Plasmodium Vivax MalariaPh 2B/3 Tafenoquine (TFQ) Study in Prevention of Vivax RelapseStudy to Evaluate the Efficacy and Safety of Tafenoquine for the Treatment of Plasmodium Vivax in AdultsPharmacokinetic Study of Primaquine and Chloroquine in Healthy SubjectsImmunization With Different Doses of Plasmodium Falciparum Sporozoites Under Chloroquine ProphylaxisEstimating the Risk of Plasmodium Vivax Relapses in AfghanistanIntermittent Preventive Treatment With Azithromycin-containing Regimens in Pregnant Women in Papua New GuineaEfficacy of Artemisinin Combination Therapies for the Treatment of Uncomplicated P. Vivax in Pregnancy in Brazil (PAACT-PV)A Phase 1 Study To Estimate The Relative Bioavailability Of Co-Administered Formulations Of Azithromycin Microsphere And Chloroquine Test Formulation Compared With Co-Administered Immediate Release Individual Azithromycin And Chloroquine TabletsDaily Trimethoprim-sulfamethoxazole or Weekly Chloroquine Among Adults on ART in MalawiComparison of Two Antimalarial Drugs Regimens in Patient With Plasmodium Vivax Malaria in ThailandComparison Between 7 and 14 Day Primaquine Combined With Dihydroartemisinin-piperaquine or 3 Day Chloroquine Radical Cure of P. Vivax (BPD)Azithromycin Plus Chloroquine Versus Artemether-Lumefantrine For The Treatment Of Uncomplicated P. Falciparum Malaria In Children In AfricaRandomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
P4844
Q61713095-761D7630-2A20-4E31-B7D1-985298751F5DQ61906879-D6B5CE05-BA12-4D82-833A-12E00D93D2CBQ61918402-FD24FEA1-B0DC-481D-A9BA-455989ACDDC5Q61920632-934F17E9-BF7A-4822-BDC0-D5289E68CC1DQ61920639-D4AAEA9C-3F66-495F-9FB7-31EA67B29B08Q61921434-974F0E6B-C705-4323-A3E0-C66D69A05979Q61933854-67F4036E-A13D-40CB-9CAF-A9C2B807D72AQ61935765-16373FAD-9D0C-42F4-8E47-441AF3A2AD2AQ61935835-42A2E762-A0A1-41AD-9B0E-5BCA645D5A60Q61938296-44FF88BA-0E48-4939-B04D-75D2DC4EB798Q61957633-32EED5DC-9A99-4E27-BF53-F318A71E9986Q61969244-5E0FC1B6-1892-42A0-9FC7-439656788292Q61980586-A5E2C556-4040-460C-A47A-74169CA8CD43Q62054370-16009E76-023B-42B1-A01F-DFD001AF15B0Q62110767-B14EF56F-F27B-47E1-8870-331F1D845C50Q62110768-8602C748-ECB2-4B19-AAB6-ECA0ED874CD4Q63229097-EC13FAB9-00AA-4821-9B20-1BD4503E7487Q63315758-CE1200B5-EB88-4132-8FE9-6552A523DC5FQ63316814-98ACE364-074F-4592-8819-8524784606FCQ63316999-BE8FD0FD-47C6-453E-A801-F1B654A3D1E7Q63321796-D450D9DC-6E47-4886-89FF-B16CEB17ED25Q63322036-9465365E-8B64-4F9A-9624-B2D56BBF5982Q63333637-3ECB34B7-979E-44EB-843B-AA9DE1A2CB92Q63340644-228A9FB5-C65C-406A-848E-F8A6A224610FQ63398409-F6C7FDB9-143F-473A-A694-E1CD7FFBF64EQ63401862-5BCABD0C-6C6D-4D1A-8B7F-0192E88E736EQ63812474-EC2D2B67-40DF-44DA-9C6F-6F1CB9AB329FQ63812644-86891BE2-E735-489B-8A6F-2C00EF1FDFA1Q63814155-33ED2812-9D5E-4FA7-8819-67740EFF6584Q63818062-20853313-B956-48A4-95E6-C92F70FDAD4CQ63818068-0F62411A-1662-456C-AED7-B790C2F0ED5CQ63829528-612E4B8A-15EC-4E7C-9029-3DDAD0C2ECD9Q63833680-1F508D06-C85B-4DFF-9B30-B9E01764EBCFQ63834047-51B7A1AE-44AC-4CA6-BA35-6BFC6C43B12AQ63835140-64853FE6-499F-4137-A0C2-2C8C8BD7426CQ63838839-1642ED4F-3ADF-4B07-8825-516416BF07F1Q63838869-E4ADF9D8-BA06-4DF7-B218-C189CBA7DB76Q63842500-7688F3D6-41FB-415F-BDB7-8DC0670D8717Q64046431-658B26DB-FCD9-44C3-A04F-F58E160A3B2AQ64123500-8EBB208A-F20C-4030-8AF2-5A1B94E3A331
P4844
Chloroquine diphosphate bearing dextran nanoparticles augmented drug delivery and overwhelmed drug resistance in Plasmodium falciparum parasites
description
im Juli 2018 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в липні 2018
@uk
name
Chloroquine diphosphate bearin ...... lasmodium falciparum parasites
@en
Chloroquine diphosphate bearin ...... lasmodium falciparum parasites
@nl
type
label
Chloroquine diphosphate bearin ...... lasmodium falciparum parasites
@en
Chloroquine diphosphate bearin ...... lasmodium falciparum parasites
@nl
prefLabel
Chloroquine diphosphate bearin ...... lasmodium falciparum parasites
@en
Chloroquine diphosphate bearin ...... lasmodium falciparum parasites
@nl
P2093
P921
P1476
Chloroquine diphosphate bearin ...... lasmodium falciparum parasites
@en
P2093
Aman Kashyap
Ashish Baldi
Jitender Madan
Ramesh Chandra
Rupinder Kaur
Upendra Kumar Jain
P304
P356
10.1016/J.IJBIOMAC.2018.03.102
P407
P577
2018-07-15T00:00:00Z